泡罩包装机外文翻译

（英文原文）BlisterPackagingMachineDrugs,alsoknownasblisterpackagingblisterpackagingeyes,orPTP(PressThroughPackaging)packagingtechnology,developedrapidlyinrecentyearsoneoftheformsofdrugpackaging.PTPtechnologyisheatedtosoftentheplasticsheetandplacedinsidethemold,orblowcompressedairthroughthevacuumpumpsothatthemethodofforming,aftertheblistersintotheeyesofmedicine,andthencoatedwithadhesivealuminumfoilmedicinalacertaintemperature,pressuresealingunderconditionstoformtheblisterpackaging.Atpresent,thepharmaceuticalblisterpackaginghasbecometablets,capsules,pillsandothersoliddosageformsthemainstreamofpackaging,thedevelopmentmomentumwillcontinue.1.BlisterPackaginginChinathestatusofdrugsWiththedeepeningofChina'sreformandopeningupandreformthehealthcaresystem,especiallyafterChina'saccessiontotheWTO,theinternationalpharmaceuticalcompaniesmoreaccesstoChina,intensifiedcompetitioninthepharmaceuticalindustryinChina,butalsoincreasedtheskillleveloftheindustryasawholeandquality,whichledtothedevelopmentofpharmaceuticalpackaging,pharmaceuticalpackagingmadeinChinaisbecomingthefieldofpackagingwithhightechnicalcontent,significantbenefitsareveryactivebranch,includingsoliddosageformsdrugsalsocontinuestointroducenewpackaging.Atpresent,theworld'stop100pharmaceuticalcompaniesinChina,almostalloftheestablishmentofjointventuresorwholly-ownedpharmaceuticalcompanies,notonlybringsmoredrugproducts,butalsoadvancedtheconceptofpharmaceuticalpackagingandstandards,butalsototheformofdrugsbroughtaboutbythediversificationofthepackaging.China'spharmaceuticalpackagingblisterformsinrecentyearsfastdevelopment,thestructureissimple,fastheatsealingequipment,increasingdemandandtheemergenceofawiderangeofchoices,includingtomeettheFDArequirementstotheintelligentrobotbasedonaluminumpackagingsystems;aswellasmanysmallanddifficulttopackageproductsprovideaneffectivesolution.Pharmaceuticalblisterpackagingmaterialsinthepastinourcountryreliesmainlyonimports,andtothepresent,withaluminumfoilandblisterpackagingblistermaterialshavebeenmade,andtomeettheneedsofthedomesticpharmaceuticalpackaging;madeintothedevelopmentofmatrixvesiclesgraduallytheformationofseries,fromthemostwidelyusedhardPVCfilms,PVDCcoatedfilmsandthecoldaluminum-plasticcompoundsheetmoldingcompositematerials,etc.;PTPalsofromaluminumfoilordouble-sidedsingle-sidedprintingblankvariety,thedevelopmentofsingle-sidedordouble-sidedgoldseries,single-sidedordouble-sidedcolorcolorseries,two-sidedprintingmonochromeormulticoloroverprintvarietiesofdozensofseries,andhard-PTPaluminumfoil,therearesoftPTPaluminumfoil,sothatthebubbleDrugsmaychoosetocovermoreofthepackaging.However,pharmaceuticalproductsinChinatheleveloftheblisterpackagingcomparedwiththedevelopedcountriesthereisabiggapbetweentheoverall,thegapcomesdowntothefollowingreasons.1)theoveralllevelofChina'spharmaceuticalindustryisrelativelylow,traditionalChinesemedicineproductionenterprisesoutdatedtechnologyhasconstrainedthedevelopmentofproductsandtheirpackaging.2)Drugslargersingledose,makingtheunitcostofblisterpackagingisstillsignificantlyhigherthanthosebottle-typepackaging,blisterpackaginghamperedinthefieldofpharmaceuticalpackaginginChinatopromotetheapplication(althoughthedrugcontrolledreleasepharmaceuticalsustained-releasetechnologyinourcountryapplications,greatlyreducingthedoseofdrugs,butnotaradicalimprovementinthepharmaceuticalpackagingblisterpackagingcostdisadvantage.3)drugdistributionsystemofthedisadvantagesoflong-termdrugsalesinthemainhospital,thereisnoprescriptionofsub-andnon-prescription,drugsatthepharmacysalesaccountforonlyasmallpartofthetotal,thissystemalsorestrictedthesaleofpharmaceuticalblisterpackagingdevelopment.4)China'spharmaceuticalpackagingequipment,automationandcannotcatchupwiththeworldadvancedlevelinthedevelopmentofblisterpackaging,blisterpackagingmakesthepromotionofdrugsobviouslylaggingbehindthepaceofadvancedcountriesintheworld;therefore,stillhavetopackagethelevelofadvancedcountriestolearn,rememberpharmaceuticalblisterpackagingwiththeworldtrend.2.China'sdrugdevelopmentdirectionofBlisterPackagingOrganizationoftheUnitedKingdommarket,accordingtonewlyreleasedinformationontheEuropeanpharmaceuticalpackagingmarketresearch,insubsequentyears,manufacturersofactivepharmaceuticalpackagingmayhaveasignificantchangeinfocus,inparticular,willshifttoblisterpackagingcontainerscardboardboxesandpackaging.Therefore,thenext5years,China'spharmaceuticalblisterpackaginginprocess,packagingmaterialsandproductionequipmentandotheraspectsstillneedfurthereffortstofasterdevelopmentofpharmaceuticalsblisterpackagingtofurtherenhancethequalityofChina'spharmaceuticalpackagingandqualityofservice,andwiththerestoftheworld.1)fullyandeffectivelyprotectthedrugs.Likewithanyformofpackagingtoprotectthedrugs,ensuretheeffectivenessofdrugsisstillthebasicrequirementsforblisterpackaging.2)Usethesafetyandconvenience.Developmentsuitableforthesafetyofthechild-friendlypackagingandpackagingtofacilitatetheelderly.3)auniqueanti-counterfeitingpackaging.Useofnewtechnologiestoachievethediversificationofblisterpackaging